Plant Summary

  Plant Information

TCMBank_ID:

TCMBANKHE006554

ID:

TCMBANKHE006554

植物拉丁名:

Radix Sanguisorbae
显示图片

功能与主治:

To arrest bleeding by dispelling heat for blood, and to counteract toxicity and cure sores./Blood ejection, hemoptysis, duodenal ulcer, spontaneous external bleeding, hematuria, hematochezia, bleeding from hemorrhoids, blood dysentery, flooding and spotting, red and white vaginal discharge, swelling pain of welling abscess and sore, eczema, pudendal itch, burns and scalds, snake or insect bites.

药用植物名:

地榆

药用部位:

root

药味:

Minor cold; Sour; Bitter

经络:

Large Intestine; Stomach; Liver

临床特征:

1. Its powder is effective for scald in experimental animals.2. Hemostatic.3. Inhibiting growth of various pathogenic bacteria.

治疗类型:

凉血止血药

TCM_ID_id:

6800

SymMap_id:

105

TCMSP_id:

216

   植物对应的化合物
化合物ID 化合物名 别名 分子式 分子质量 Smiles
TCMBANKIN001429 sauvissimoside R1 696.92
TCMBANKIN001920 3β-[(α-l-arabinopyranosyl)oxy]-urs-12,19-dien-28-oicacid C35H54O7 CC1=C(C2C3=CCC4C5(CCC(C(C5CCC4(C3(CCC2(CC1)C(=O)O)C)C)(C)C)OC6C(C(C(CO6)O)O)O)C)C
TCMBANKIN002188 sanguisorbin B _qt 456.78
TCMBANKIN002550 leucocyanidin (2R,3R,4R)-2-(3,4-DIHYDROXYPHENYL)-3,4-DIHYDRO-2H-1-BENZOPYRAN-3,4,5,7-TETROL; ZINC4096940; (2R)-2alpha-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3alpha,4alpha,5,7-tetrol; 867061-09-4 C15H14O7 306.27 g/mol C1=CC(=C(C=C1C2C(C(C3=C(C=C(C=C3O2)O)O)O)O)O)O
TCMBANKIN002657 sanguiinh8 sanguiin h8 C54H42O36 1266.9 g/mol C1C2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)O)O)OC(=O)C4=C(C5=C(C(=C(C=C5C(=O)O1)O)O)O)C(=C(C(=C4OC6=CC(=CC(=C6O)O)C(=O)OC7C8C(C(C(O7)CO)O)OC(=O)C9=CC(=C(C(=C9C1=C(C(=C(C=C1C(=O)O8)O)O)O)O)O)O)O)O)O
TCMBANKIN002807 sanguisorbic acid dilactone C21H10O13 470.3 g/mol C1=C(C=C(C(=C1O)O)OC2=C(C(=O)C3=C4C2=C(OC5=C4C(=C(O3)O)C=C(C5=O)O)O)O)C(=O)O
TCMBANKIN003225 sanguisorbin E_qt 660.98
TCMBANKIN003958 3β-[(α-l-arabinopyranosyl)oxy]-urs-11,13(18)-dien-28-oicacid β-d-glucopyranosyl ester C41H64O12 CC1CCC2(CCC3(C(=C2C1C)C=CC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(CO6)O)O)O)C)C)C)C(=O)OC7C(C(C(C(O7)CO)O)O)O
TCMBANKIN006449 gallic acid 3-O-β-D-(6'-O-galloyl)glucopyranoside 482.43
TCMBANKIN007004 2-methyl-1,3,6-trihydroxy-9,10-anthraquinone3-o-(α-l-rhamnopyranosyl-(1→2)(6'-acetyl)-β-d-glucopyranoside) C29H32O15
TCMBANKIN007844 3β-[(α-l-arabinopyranosyl)oxy]-19α-hydroxy-urs-12-en-28-oicacid C35H56O8
TCMBANKIN008482 b-sitostero-b-d-glycoside
TCMBANKIN008594 3, 11-dioxo-19alpha-hydrooxyurs-12-en 28-oic acid 3,11-dioxo-19alpha-hydrooxyurs-12-en 28-oic acid
TCMBANKIN008958 pomolicacid-28-o-β-d-glucopyranoside
TCMBANKIN009619 suavissimosider1 suavissimoside R1 C36H56O12 680.8 g/mol CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C(=O)O)O)O)C)C)C2C1(C)O)C)C(=O)OC6C(C(C(C(O6)CO)O)O)O
TCMBANKIN010239 3β-[(α-l-arabinopyranosyl)oxy]-19α-hydroxy-urs-12-en-28-oicacid 28-(6-o-galloyl-β-d-glucopyranosyl)ester C48H70O17 CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(CO6)O)O)O)C)C)C2C1(C)O)C)C(=O)OC7C(C(C(C(O7)COC(=O)C8=CC(=C(C(=C8)O)O)O)O)O)O
TCMBANKIN010478 glucoside gallate
TCMBANKIN011283 3β,19α-dihydroxyursan-28-oicacid C30H50O4
TCMBANKIN012498 cyanin LMPK12010113; Cyanidin 3,5-diglucoside; cyanine; Cyanin C27H31O16+ 611.5 g/mol C1=CC(=C(C=C1C2=C(C=C3C(=CC(=CC3=[O+]2)O)OC4C(C(C(C(O4)CO)O)O)O)OC5C(C(C(C(O5)CO)O)O)O)O)O
TCMBANKIN013955 chrysanthemol chrysanthemol ; ZINC15208543; MolPort-044-723-367; (+)-Chrysanthemol[terpene] C10H18O 154.25 g/mol CC(=CC1C(C1(C)C)CO)C
TCMBANKIN014217 3-o-gallpylprocyanidin b3
TCMBANKIN014466 sanguiinh3 sanguiin h3 C68H48O44 1569.1 g/mol C1C2C(C3C(C(O2)C(=O)OC4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5C6=C(C(=C(C=C6C(=O)O3)O)O)O)O)O)O)OC(=O)C7=C(C8=C(C(=C(C=C8C(=O)O1)O)O)O)C(=C(C(=C7OC9=CC(=CC(=C9O)O)C(=O)OC1C2C(C(C(O1)CO)O)OC(=O)C1=CC(=C(C(=C1C1=C(C(=C(C=C1C(=O)O2)O)O)O)O)O)O)O)O)O
TCMBANKIN015165 sanguiinh5
TCMBANKIN015388 sauvissimoside R1_qt 534.76
TCMBANKIN016023 1-(2,4-dihydroxy-6-methoxyphenyl)ethanone 1-(2,4-dihydroxy-6-methoxy-phenyl)ethanone C9H10O4 182.17 g/mol CC(=O)C1=C(C=C(C=C1OC)O)O
TCMBANKIN016308 euphadienol C30H50O 426.7 g/mol CC(CCC=C(C)C)C1CCC2(C1(CCC3=C2CCC4C3(CCC(C4(C)C)O)C)C)C
TCMBANKIN016405 3,3',4-tri-O-methylellagic acid 3,3', 4-tri-o-methylellagic acid; 3,3',4-tri-o-methylellagic acid; 3,3',4-tri-o-methyl ellagicacid; 3,3',4-tri-o-methyl ellagic acid 346.31
TCMBANKIN017257 3,11-dioxo-19α-hydroxyurs-12-en-28-oic acid 484.74
TCMBANKIN017412 galloylhamame lose C13H16O10 332.26 g/mol C1=C(C=C(C(=C1O)O)O)C(=O)C(=O)C(CO)(C(C(CO)O)O)O
TCMBANKIN018076 3,5,6-trihydroxy-phytosteranes
TCMBANKIN019167 sanguisobicacid dilactone sanguisobic acid dilactone C1=C(C=C(C(=C1O)O)OC2=C(C(=C3C4=C2C(=O)OC5=C4C(=CC(=C5O)O)C(=O)O3)O)O)C(=O)O
TCMBANKIN019659 3-O-galloylprocyanidin B-3 730.67
TCMBANKIN019792 omolic acid-28-O-β-D-glucopyranoside_qt 470.81
TCMBANKIN020041 euphorbone
TCMBANKIN020828 1β,2α,3α,19α-tetrahydroxyurs-12-en-28-oicacid C30H48O6 CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(C(C(C(C5(C)C)O)O)O)C)C)C2C1(C)O)C)C(=O)O
TCMBANKIN021031 3β-[(α-l-arabinopyranosyl)oxy]-23-hydroxy-urs-12,19(29)-dien-28-oicacid 28-β-d-gluco-pyranosyl ester C41H64O13 CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)CO)OC6C(C(C(CO6)O)O)O)C)C)C2C1=C)C)C(=O)OC7C(C(C(C(O7)CO)O)O)O
TCMBANKIN021211 sanguiinh10 sanguiin h10 C68H48O44 1569.1 g/mol C1C2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)OC4=C(C(=C(C5=C4C(=O)OC6C(COC(=O)C7=CC(=C(C(=C75)O)O)O)OC(C8C6OC(=O)C9=CC(=C(C(=C9C2=C(C(=C(C=C2C(=O)O8)O)O)O)O)O)O)OC(=O)C2=CC(=C(C(=C2)O)O)O)O)O)O)O)O)O)O)OC(=O)C2=CC(=C(C(=C2C2=C(C(=C(C=C2C(=O)O1)O)O)O)O)O)O
TCMBANKIN022566 Diosphenol SCHEMBL873797; C09854; EINECS 207-704-9; AC1L2WHG; AC1Q6D64; QSIMLPCPCXVYDD-UHFFFAOYSA-N; Buchu camphor; 1-p-menthen-2-ol-3-one; CTK8I8590; LMPR0102090061; Barosma camphor; AKOS022505068; 2-Cyclohexen-1-one, 2-hydroxy-3-methyl-6-(1-methylethyl)-; DTXSID5052127; diosphenol; Buccocamphor; AN-21384; 2-hydroxy-3-methyl-6-propan-2-ylcyclohex-2-en-1-one; 2-Hydroxy-6-isopropyl-3-methyl-2-cyclohexen-1-one; 2-Hydroxy-6-isopropyl-3-methyl-2-cyclohexen-1-one #; 2-hydroxy-3-methyl-6-(propan-2-yl)cyclohex-2-en-1-one; 2-hydroxy-6-isopropyl-3-methyl-cyclohex-2-en-1-one; 2-Hydroxypiperitone; 490-03-9; CHEBI:4632; 2-Hydroxy-6-(isopropyl)-3-methylcyclohex-2-en-1-one C10H16O2 168.23 CC1=C(C(=O)C(CC1)C(C)C)O
TCMBANKIN024550 3β-[(α-l-arabinopyranosyl)oxy]-urs-12,19(29)-dien-28-oicacid C35H54O7 CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(CO6)O)O)O)C)C)C2C1=C)C)C(=O)O
TCMBANKIN024747 methyl dihydrojasmonate SCHEMBL113648; Jsp004945 C13H22O3 226.31 g/mol CCCCCC1C(CCC1=O)CC(=O)OC
TCMBANKIN025069 sanguiinh1 sanguiin h1 C34H26O22 786.6 g/mol C1=C(C=C(C(=C1O)O)O)C(=O)OCC2C(C3C(C(O2)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5C6=C(C(=C(C=C6C(=O)O3)O)O)O)O)O)O)O
TCMBANKIN025443 omolic acid-28-O-β-D-glucopyranoside 632.97
TCMBANKIN025490 methyl-2,3,6-tri-O-galloyl-β-D-glucopyranoside 654.68
TCMBANKIN025756 (+)-Catechin-7-gallate AIDS071292; 3,4,5-Trihydroxy-benzoic acid (2R,3S)-2-(3,4-dihydroxy-phenyl)-3,5-dihydroxy-1-benzopyran-7-yl ester; 3,4,5-trihydroxybenzoic acid [(2R,3S)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-chromanyl] ester; (+)-Catechin-7-O-gallate; AIDS-071292; [(2R,3S)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-chroman-7-yl] 3,4,5-trihydroxybenzoate; 3,4,5-trihydroxybenzoic acid [(2R,3S)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-chroman-7-yl] ester; [(2R,3S)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxychroman-7-yl] 3,4,5-trihydroxybenzoate C22H18O10 442.4 g/mol C1C(C(OC2=CC(=CC(=C21)O)OC(=O)C3=CC(=C(C(=C3)O)O)O)C4=CC(=C(C=C4)O)O)O
TCMBANKIN026948 3β-[(α-l-arabinopyranosyl)oxy]-19α-hydroxy-olean-12-en-28-oicacid C35H56O8
TCMBANKIN027270 3β-[(α-l-arabinopyranosyl)oxy]-19α-hy-droxyurs-12-en-28-oicacid 28-β-d-glucopyra-nosyl ester C41H66O13
TCMBANKIN028082 ziyu glycoside ii (1R,4aS,6bR,10S,12aR,14bS)-1-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-10-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; ziyu-glycoside ii; AC1O44KH C35H56O8 604.8 g/mol CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(CO6)O)O)O)C)C)C2C1(C)O)C)C(=O)O
TCMBANKIN028342 sanguisorbin a
TCMBANKIN029137 3β-[(α-l-arabinopyranosyl)oxy]urs-12,18-dien-28-oicacid C35H54O7 CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(CO6)O)O)O)C)C)C2=C1C)C)C(=O)O
TCMBANKIN029178 sanguiinh7 sanguiin h7 C34H26O23 802.6 g/mol C1C2C(C(C(C(O2)O)OC(=O)C3=CC(=C(C(=C3)O)O)O)O)OC(=O)C4=C(C5=C(C(=C(C=C5C(=O)O1)O)O)O)C(=C(C(=C4OC6=CC(=CC(=C6O)O)C(=O)O)O)O)O
TCMBANKIN030711 sanguiinh11 sanguiin h-11 ; sanguiin h11 C41H28O26 936.6 g/mol C1C2C(C3C(C(O2)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5C6=C(C(=C(C=C6C(=O)O3)O)O)O)O)O)O)OC(=O)C7=CC(=C(C(=C7C8=C(C(=C(C=C8C(=O)O1)O)O)O)O)O)O
TCMBANKIN031914 hespertitinic acid
TCMBANKIN032070 inegnol
TCMBANKIN032988 3β-[(α-l-arabinopyranosyl)oxy]-19β-hydroxy-urs-12,20(30)-dien-28-oicacid C35H54O8 CC1(C2CCC3(C(C2(CCC1OC4C(C(C(CO4)O)O)O)C)CC=C5C3(CCC6(C5C(C(=C)CC6)(C)O)C(=O)O)C)C)C
TCMBANKIN033707 methyl 6- O-digalloyl-β-glucopyranoside 498.43
TCMBANKIN033960 3,4,4-tri-o-methylellagic acid 3, 4, 4-tri-o-methylellagic acid
TCMBANKIN034521 beta-euphorbol
TCMBANKIN035002 sanguiinh9 sanguiin h9 C54H42O36 1266.9 g/mol C1C2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)OC4=C(C(=C(C5=C4C(=O)OC6C(COC(=O)C7=CC(=C(C(=C75)O)O)O)OC(C(C6O)O)OC(=O)C8=CC(=C(C(=C8)O)O)O)O)O)O)O)O)O)O)OC(=O)C9=CC(=C(C(=C9C2=C(C(=C(C=C2C(=O)O1)O)O)O)O)O)O
TCMBANKIN035264 3β-[(α-l-arabinopyranosyl)oxy]urs-12,19(29)-dien-28-oicacid 28-β-d-glucopyranosyl ester C41H64O12 CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(CO6)O)O)O)C)C)C2C1=C)C)C(=O)OC7C(C(C(C(O7)CO)O)O)O
TCMBANKIN036155 Ziziphin SCHEMBL350002; CHEBI:10120; 73667-51-3; AC1L9C02; ziziphin; C08991 C51H80O18 981.17 CC1C(C(C(C(O1)OC2COC(C(C2O)O)OC3CCC4(C5CCC6C7C(CC(OC78CC6(C5(CCC4C3(C)C)C)CO8)C=C(C)C)(C)OC9C(C(C(C(O9)C)O)OC(=O)C)OC(=O)C)C)O)O)O
TCMBANKIN036503 alexandrin_qt daucosterin_qt C35H60O6 576.85
TCMBANKIN036785 daucostero_qt strumaroside _qt; β-sitosterol-3-O-β-D-glucopyranoside_qt; daucosterol_qt C35H60O6 576.85
TCMBANKIN036829 ursolic acid ursolicacid; U6753_SIGMA; AIDS-039057; AKOS022168209; Urs-12-en-28-oic acid, 3beta-hydroxy- (8CI); 77-52-1; s2370; 3beta-Hydroxyurs-12-en-28-oic acid; SMR000445681; NSC4060; MLS000728569; Ursolic acid; TOS-BB-0966; 3beta-Hydroxy-12-ursen-28-ic acid; (1S,2R,4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,4a,5,6,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-1H-picene-4-carboxylic acid; ursolic acid ; BSPBio_000018; NSC 167406; H719; 89797_FLUKA; EINECS 201-034-0; Prunol; BPBio1_000020; (1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid; AI3-03109; CHEBI:9908; ST056289; Ursolicacid; AC-8029; Urs-12-en-28-oic acid, 3-hydroxy-, (3beta)-; Ursolic acid (Malol); CCRIS 7123; BC216337; Urson; (3beta)-3-Hydroxyurs-12-en-28-oic acid; Prestwick3_000089; Malol; C08988; AKOS015965499; SCHEMBL1699371; MolPort-016-633-342; 209545-05-1; AS-13246; AIDS039057; NSC 4060 C30H48O3 456.7 CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C(=O)[O-]
TCMBANKIN036863 hesperidin Hesperetin 7-O-rutinoside; Flavanone, 3',5,7-trihydroxy-4'-methoxy-, 7-(6-O-alpha-L-rhamnosyl-delta-glucoside) (7CI); (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-2-tetrahydropyranyl]oxymethyl]-2-tetrahydropyranyl]oxy]-4-chromanone; 15512-51-3; Hesperitin-7-rhamnoglucoside; (2S)-5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxymethyl]oxan-2-yl]oxy-chroman-4-one; Hesperetin-rutinosid; 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-((6-O-alpha-L-rhamnopyranosyl-beta-D-glucopyranosyl)oxy)-4-chromanon; 520-26-3; CHEBI:28775; (S)-7-[[6-O-(6-Deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one; (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychroman-4-one; 5-18-05-00218 (Beilstein Handbook Reference); hesperidin ; BSPBio_000619; Hesperidin; BRN 0075140; Atripliside B; 7-((6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one, (S)-; D01038; BCBcMAP01_000136; 3',5'-Dihydroxy-4'-methoxy-7-rutinosyloxyflavan-4-on; 7-(6-O-Desoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyloxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-chromanon; (2S)-5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chroman-4-one; CCRIS 3940; Flavanone, 3',5,7-trihydroxy-4'-methoxy-, 7-(6-O-a-L-rhamnosyl-D-glucoside) (7CI); Glucopyranoside, hesperetin-7 6-O-(6-deoxy-alpha-L-mannopyranosyl)-, beta-D-; NSC 44184; (S)-(--)-hesperidin; (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside; Prestwick3_000400; 106904-63-6; 28283-75-2; Hesperidine; C09755; AIDS-001414; 16643-24-6; SMP1_000149; Ciratin; Hesperetin, 7-(6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside); Hesperidin (JAN); 17654-22-7; 32737-61-4; 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydo-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (S)-; Hesperetin-rutinoside; EINECS 208-288-1; STOCK1N-12322; AIDS001414; BPBio1_000681; 30927-97-0; Hesper bitabs; 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (2S)-; (2S)-Hesperidin C28H34O15 611 C([H])([H])([H])[C@]1([H])O[C@@]([H])(OC([H])([H])[C@]2([H])O[C@]([H])(Oc3c([H])c(O[C@@]([H])(c4c([H])c([H])c(OC([H])([H])[H])c(O[H])c4[H])C([H])([H])C5=O)c5c(O[H])c3[H])[C@@]([H])(O[H])[C@]([H])(O[H] )[C@@]2([H])O[H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]1([H])O[H]
TCMBANKIN036880 diosmin 520-27-4; C10039; 5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chromen-4-one; 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.- D-glucopyranosyl)oxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-; Diosmin [INN]; Diosmetin 7-O-rutinoside; AIDS059330; Diosmine [INN-French]; 5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxymethyl]oxan-2-yl]oxy-chromen-4-one; Diosminum [INN-Latin]; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-2-tetrahydropyranyl]oxymethyl]-2-tetrahydropyranyl]oxy]-4-chromenone; AIDS-059330; Diosmin [INN-Spanish]; 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-; 5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chromone; CCRIS 7915; SMP1_000183; EINECS 208-289-7; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one; D3908; diosmin ; Diosmin; STOCK1N-14729 C28H32O15 608.5 g/mol CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O
TCMBANKIN037794 kansuinine A ZINC95616043; CHEMBL509463; Kansuinine A; Kansuinin A; MolPort-039-338-487; 57701-86-7 C36H44O15 717 [C@@]1([H])(C([H])([H])[H])C([H])([H])[C@](OC(C([H])([H])[H])=O)([C@]2(O[H])O[C@]([H])(C(C([H])([H])[H])(C([H])([H])[H])[C@]([H])(OC(C([H])([H])[H])=O)[C@]([H])(OC(=O)c(c([H])c([H])c3[H])c([H])c3[H])[ C@]([H])(OC(C([H])([H])[H])=O)C(=C([H])[H])[C@]4([H])OC(C([H])([H])[H])=O)C(=O)C2([H])[H])[C@]4([H])[C@@]1([H])OC(C([H])([H])[H])=O
TCMBANKIN038513 Methyl 2,3,4,6-tetra-O-galloyl-beta-D-glucopyranoside methyl 2,3,4,6-tetra-o-galloyl-β-d-glucopyra-noside C35H30O22 802.6 g/mol c1(O[H])c(O[H])c([H])c(C(OC([H])([H])[C@@]2([H])O[C@]([H])(OC([H])([H])[H])[C@]([H])(OC(c3c([H])c(O[H])c(O[H])c(O[H])c3[H])=O)[C@@]([H])(OC(c4c([H])c(O[H])c(O[H])c(O[H])c4[H])=O)[C@]2([H])OC(c5c([H])c (O[H])c(O[H])c(O[H])c5[H])=O)=O)c([H])c1O[H]
TCMBANKIN038809 Methyl 6-O-digalloyl-β-D-glucopyranoside II
TCMBANKIN038940 cyclo-(gly-leu-pro-trp-leu-ile-ala-ala) C42H63N9O8 822 g/mol CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)N1)CC(C)C)CC3=CNC4=CC=CC=C43)CC(C)C)C)C
TCMBANKIN039565 Methyl 4,6-di-O-galloyl-beta-D-glucopyranoside [(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-methoxy-2-[(3,4,5-trihydroxyphenyl)carbonyloxymethyl]oxan-3-yl] 3,4,5-trihydroxybenzoate; 3,4,5-trihydroxybenzoic acid [(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-methoxy-2-[(3,4,5-trihydroxybenzoyl)oxymethyl]tetrahydropyran-3-yl] ester; 3,4,5-trihydroxybenzoic acid [(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-methoxy-2-[[oxo-(3,4,5-trihydroxyphenyl)methoxy]methyl]-3-tetrahydropyranyl] ester; [(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-methoxy-2-[(3,4,5-trihydroxybenzoyl)oxymethyl]tetrahydropyran-3-yl] 3,4,5-trihydroxybenzoate; [(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-methoxy-2-[(3,4,5-trihydroxybenzoyl)oxymethyl]oxan-3-yl] 3,4,5-trihydroxybenzoate; methyl 4,6-di-o-galloyl-beta-d-glucopyranoside; methyl 4,6-di-o-galloyl-β-d-glucopyranoside C21H22O14 498.391 c1(O[H])c([H])c(C(OC([H])([H])[C@]([H])([C@@]([H])(OC(=O)c2c([H])c(O[H])c(O[H])c(O[H])c2[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]3([H])OC([H])([H])[H])O3)=O)c([H])c(O[H])c1O[H]
TCMBANKIN039643 Cyclo-(Gly-Asp-Leu-Thr-Val-Tyr-Phe) 795.9 g/mol
TCMBANKIN039925 rosamultin CHEMBL501885; [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl] (1R,2R,4aS,6aR,6aS,6bR,8aR,10R,11R,12aR,14bS)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate; .beta.-D-Glucopyranose, 1-O-[(2.alpha.,3.beta.)-2,3,19-trihydroxy-28-oxours-12-en-28-yl]-; rosamultin ; ZINC67902677; 88515-58-6; Rosamultin; Rosamutin C36H58O10 651 [C@@]1([H])(C([H])([H])[H])[C@@](C([H])([H])[H])(O[H])[C@@]([H])(C(=C([H])C([H])([H])[C@]([H])([C@@](C([H])([H])[H])(C([H])([H])[C@@]([H])(O[H])[C@@]([H])(O[H])C2(C([H])([H])[H])C([H])([H])[H])[C@@]2( [H])C([H])([H])C3([H])[H])[C@@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@]5(C(=O)O[C@@]6([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O6)C([H])([H ])C1([H])[H]
TCMBANKIN040792 (cis-head-to-head)-Limettin dimer
TCMBANKIN042462 3,5,6-Trihydroxy-7,4'-dimethoxyflavone 3,5,6-Thdmof; DTXSID80244086; 3,5,6-Trihydroxy-7,4'-dimethoxyflavone; AC1NT15C; LMPK12112872; 4H-1-Benzopyran-4-one, 3,5,6-trihydroxy-2-(4-methoxyphenyl)-; 3,5,6-trihydroxy-7-methoxy-2-(4-methoxyphenyl)chromen-4-one; 3,5,6-Trihydroxy-4',7'-dimethoxyflavone; 99499-82-8 330.29 g/mol
TCMBANKIN042479 kansuinine b Kansuinine B; SCHEMBL1231379; CHEMBL3813747; 57685-46-8; AC1L9C65; C09122; Kansuinin B; CHEMBL448506; DTXSID80331728; CHEBI:6111; MolPort-044-754-172 C38H42O14 722.73 CC1C2C(O2)C(C(=O)C(C(C(=C)C(C3C(C(C(C3(C1=O)OC(=O)C)O)(C)O)OC(=O)C)OC(=O)C4=CC=CC=C4)OC(=O)C5=CC=CC=C5)O)(C)C
TCMBANKIN044562 l-beta-cyanolanine 114.103
TCMBANKIN045329 methyl 3,4,6-tri-o-galloyl-β-d-glucopyranoside Methyl 3-O,4-O,6-O-trigalloyl-beta-D-glucopyranoside; [(2R,3R,4R,5R,6R)-5-hydroxy-6-methoxy-3,4-bis[(3,4,5-trihydroxybenzoyl)oxy]oxan-2-yl]methyl 3,4,5-trihydroxybenzoate; AC1NSYMS; methyl 3,4,6-tri-o-galloyl-beta-d-glucopyranoside C28H26O18 650.5 g/mol COC1C(C(C(C(O1)COC(=O)C2=CC(=C(C(=C2)O)O)O)OC(=O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O)O
TCMBANKIN045380 Methyl 2,3,6-tri-O-galloyl-β-D-glucopyranoside methyl 2,3,6-tri-o-galloyl-beta- d-glucopyranoside 650.5 g/mol
TCMBANKIN049841 (cis-head-to-tail)-limettin dimer COC1=CC(=C2C3C(C4C3C(=O)OC5=CC(=CC(=C45)OC)OC)C(=O)OC2=C1)OC
TCMBANKIN050197 Sanguisorbin E sanguisorbin E 792.99
TCMBANKIN058060 gallic acid Spectrum4_001544; NSC-755825; 4CN-0954; KBio2_000822; NCGC00260064-01; KBio3_001168; CHEBI:30778; GTPL5549; D0Y3TZ; NCGC00091125-01; 632XD903SP; ARONIS23903; Spectrum5_000108; Jsp002851; T7419; Gallic acid, puriss., 98.0%; I14-9302; NCGC00091125-07; ZINC1504; 3,4,5-trihydroxybenzoic acid (ACD/Name 4.0); KBioGR_002008; AK-65266; pyrogallol-5-carboxylate; BRD-K77345217-001-01-9; Gallicum acidum; LNTHITQWFMADLM-UHFFFAOYSA-N; KBio2_003390; EBD679760; NCGC00091125-04; AJ-08037; Gallic acid; ZB000350; BG01502846; A808977; (?)-Gallic acid; WLN: QVR CQ DQ EQ; N1830; AC1NEVA5; SBB008781; 149-91-7; GALLIC ACID ANHYDROUS; Gallic acid [NF]; KS-00000IWM; CS-8191; LS-870; C01424; KS-00004784; CHEBI:16918; SPECTRUM210369; c0006; UNII-632XD903SP; ACMC-20aku5; CTK0H5618; BIDD:ER0374; AC1Q732X; NCGC00091125-02; F1908-0156; Oprea1_087792; CG0029; DSSTox_RID_75711; Kyselina 3,4,5-trihydroxybenzoova; 3-10-00-02070 (Beilstein Handbook Reference); RP23206; NSC36997; Gallic acid, certified reference material, TraceCERT(R); AI3-16412; CCG-38670; STK298718; Tox21_202515; bmse000389; AN-15162; AB00052697_03; SR-05000001537-2; NSC-36997; 1886-EP2374526A1; 5-Carboxybenzene-1,2,3-triol; KBio2_005958; SR-05000001537-3; NCGC00091125-05; KBio1_001347; Kyselina gallova [Czech]; KSC175M1R; KBioSS_000822; HMS2091A07; gallate; CPD-183; Spectrum3_000254; 78563C7D-0E2D-4766-A8EA-670A03C78FCF; gallic acid ; InChI=1/C7H6O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1-2,8-10H,(H,11,12; GDE; SBI-0052184.P002; EINECS 205-749-9; CAS-149-91-7; Kyselina gallova; J3.617.291F; Benzoic acid, 3,4,5-trihydroxy-; BG00601456; DivK1c_006403; Benzoic acid,4,5-trihydroxy-; gallic acid for microelectronic industrial; BRN 2050274; Gallic acid tech.; NCGC00091125-03; Kyselina 3,4,5-trihydroxybenzoova [Czech]; Gallic acid, 97.5-102.5% (titration); gallicacid; 3,4,5-Trihydroxybenzoic acid, anhydrous; NSC674319; TR-020762; 3,4,5-tris(oxidanyl)benzoate; MCULE-1552954312; Gallic acid polymer; Pharmakon1600-00210369; BSPBio_001668; Tox21_111089; HMS1923K07; CCRIS 5523; BDBM50085536; NSC-674319; ST2404570; BB_SC-2795; AC-1206; 3,4,5-trihydroxy-Benzoic acid; Gallic Acid Hydrate; AC1L1934; RTR-020762; GALOP; Q-201146; SR-05000001537-1; DSSTox_CID_650; 3,4,5-Trihydroxybenzoic acid monohydrate, ACS, 98.0% min. 100g; 3,4,5-Trihydroxybenzoic acid ion; GALLICACID; s4603; CHEMBL288114; Gallic acid, tech.; NSC20103; 3,4,5-Trihydroxybenzoic acid; NSC755825; G0011; AB1002218; Gallic Acid, F; MolPort-000-881-260; NSC 674319; SPBio_000617; LNTHITQWFMADLM-UHFFFAOYSA-M; Spectrum_000342; PS-8710; SC-46383; FT-0626592; BBL009937; MFCD00002510; SpecPlus_000307; 3,4,5-trihydroxy-Benzoate; SCHEMBL15012; DSSTox_GSID_20650; ST083487; SR-05000001537; 3,5-Trihydroxybenzoic acid; 3,4,5-Trihydroxybenzoate, X; Tox21_111089_1; Gallic acid (Monohydrate or Anhydrous) (3,4,5-Trih; 3,4,5-Trihydroxybenzoic acid;; Z966690556; 3,4,5-Trihydroxybenzoate; SDCCGMLS-0066503.P001; Pyrogallol-5-carboxylic acid; BC200279; Spectrum2_000399; HY-N0523; HSDB 2117; AC1Q732Y; DTXSID0020650; 5-Trihydroxybenzoic acid; AKOS000119625; NSC 20103; Gallic acid, tech; 138-57-8; NSC-20103; AIDS-001349; gallate; CPD-183; Spectrum3_000254; KBio2_000822; Gallic acid monohydrate; AIDS-059239; KBio3_001168; Gallic acid, tech.; NSC20103; 3,4,5-Trihydroxybenzoic acid; InChI=1/C7H6O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1-2,8-10H,(H,11,12; C01424; CHEBI:30778; EINECS 205-749-9; CHEBI:16918; NCGC00091125-01; c0006; J3.617.291F; SPECTRUM210369; Benzoic acid, 3,4,5-trihydroxy-; DivK1c_006403; NSC 674319; SPBio_000617; LNTHITQWFMADLM-UHFFFAOYSA-M; Spectrum_000342; Spectrum5_000108; NCGC00091125-02; BRN 2050274; Oprea1_087792; NCGC00091125-03; 3-10-00-02070 (Beilstein Handbook Reference); SpecPlus_000307; Kyselina 3,4,5-trihydroxybenzoova [Czech]; KBioGR_002008; AI3-16412; NSC674319; pyrogallol-5-carboxylate; 3,4,5-tris(oxidanyl)benzoate; AIDS001349; KBio2_003390; Gallic acid polymer; 1886-EP2374526A1; ZB000350; Gallic acid; BSPBio_001668; KBio2_005958; AIDS059239; CCRIS 5523; 3,4,5-Trihydroxybenzoate; SDCCGMLS-0066503.P001; Pyrogallol-5-carboxylic acid; A808977; 27645_RIEDEL; KBio1_001347; 398225_SIAL; Kyselina gallova [Czech]; WLN: QVR CQ DQ EQ; Spectrum2_000399; HSDB 2117; G7384_SIGMA; KBioSS_000822; GALOP; AC1NEVA5; SBB008781; 3,4,5-Trihydroxybenzoic acid monohydrate, ACS, 98.0% min. 100g; NSC 20103; 3,4,5-Trihydroxybenzoic acid ion; 149-91-7; 3,4,5-trihydroxybenzoic acid; Galllic acid C7H6O5 170.12 C1=C(C=C(C(=C1O)O)O)C(=O)O
TCMBANKIN058062 sanguiinh4 sanguiin h4 C27H22O18 634.5 g/mol C1=C(C=C(C(=C1O)O)O)C(=O)OC2C3C(C(C(O2)CO)O)OC(=O)C4=CC(=C(C(=C4C5=C(C(=C(C=C5C(=O)O3)O)O)O)O)O)O
TCMBANKIN058067 1,2,6-tri-O-galloyl-β-D-glucose;1,2,6-trigalloylglucose;1,2,6-tri-o-galloyl-glucose;1,2,6-tri-o-galloyl-beta-d-glucopyranoside 1,2,6-tri-o-galloyl-β-d-glucose 470.76 C1=C(C=C(C(=C1O)O)O)C(=O)OCC2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O)O)O
TCMBANKIN058126 chrysanthemin cyanidin-3-glucoside; Chrysanthemin; LMPK12010110; cyanidin 3-glucoside; Cyanidin 3-O-glucoside; cyanidin 3-o-glucoside; cyanidin-3-O-glucoside C28H58O 410.76 C1=CC(=C(C=C1C2=[O+]C3=CC(=CC(=C3C=C2OC4C(C(C(C(O4)CO)O)O)O)O)O)O)O
TCMBANKIN058130 quercetin-３-Ｏ-galactoside hyperin; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; SMR000466394; C10073; ACon1_000623; Quercetin 3-O-beta-D-galactopyranoside; Quercetin-3-O-galactoside;p Hyperin; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-; 482-36-0; Hyperin; Quercetin 3-galactoside; AIDS026341; Hyperasid; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone; NSC 407304; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone; Quercetin-3-O-galactoside; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; Hyperozide; AIDS-026341; MLS000759538; Quercetin 3-D-galactoside; EINECS 207-580-6; Quercetin-3-galactoside; Hyperin (8CI); Hyperoside; 2-(3,4-Dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one; 83388_FLUKA; MEGxp0_000392; Hyperosid; Quercetin 3-beta-D-galactopyranoside C21H19O12- 463.4 g/mol C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)[O-]
TCMBANKIN058213 kaemferol;kampferol;kaempferol;campherol TNP00039; nchembio.2007.28-comp30; Kaempherol; 5-18-05-00251 (Beilstein Handbook Reference); Prestwick2_001098; CHEBI:28499; Prestwick1_001098; CAS-520-18-3; BRN 0304401; Flavone, 3,4',5,7-tetrahydroxy-; ST030560; MEGxp0_001283; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-5,7,4'-Trihydroxyflavonol; C.I. 75640; Swartziol; K0133_SIGMA; kaempferol oxoanion; NCGC00016480-01; 60010_FLUKA; EINECS 208-287-6; Pelargidenon; Nimbecetin; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4-chromenone; NSC 407289; 3,4',5,7-Tetrahydroxyflavone; HSCI1_000027; Pelargidenolon 1497; NSC407289; Robigenin; C05903; CPD1F-90; Kampferol; NSC 656277; Prestwick0_001098; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one; Populnetin; Kampcetin; Prestwick3_001098; AIDS-001404; ZINC00137345; kaempferol ; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-olate; 3,4′,5,7-Tetrahydroxyflavone; Rhamnolutein; NCGC00016480-02; ACon1_001867; NSC656277; 3,4′,5,7-Tetrahydroxyflavone; BSPBio_001176; SPBio_003058; Oprea1_650954; 5,7,4'-Trihydroxyflavonol; 4H-1-Benzopyran-4-one,3,5,7-trihydroxy-2-(4-hydroxyphenyl)-5,7,4'-Trihydroxyflavonol; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)- (9CI); Campherol; 520-18-3; 3,5,7-TRIHYDROXY-2-(4-HYDROXYPHENYL)-4H-CHROMEN-4-ONE; S00111; Trifolitin; Kampherol; AI3-36096; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromone; Indigo yellow; Pelargidenolon; AIDS001404; nchembio718-comp14; NCGC00091036-01; Flavone, 3,4',5,7-tetrahydroxy- (7CI,8CI); CHEBI:58573; Kaemferol; Kempferol; BPBio1_001294; 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; Rhamnolutin; 3,5,7-triOH-Flavone; KMP; CCRIS 41; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)- C15H10O6 286.24 g/mol C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O
TCMBANKIN058288 catechol 430749_ALDRICH; Catechin (phenol); Pyrokatechin [Czech]; NCGC00015283-01; Catechol-UL-14C; NCI-C55856; CI Oxidation Base 26; CHEBI:18135; benzene-1,2-diol; C15571; 120-80-9; InChI=1/C6H6O2/c7-5-3-1-2-4-6(5)8/h1-4,7-8; C9510_SIAL; Fouramine PCH; 135011_SIAL; Lopac-C-9510; 2-hydroxyphenol; NSC 1573; NCGC00091262-01; Fourrine 68; o-Diphenol; C.I. Oxidation Base 26; o-Dioxybenzene; C00090; ST5214346; (1,2,3,4,5,6-(1)?C?)BENZENE-1,2-DIOL; AB-131/40235236; Lopac0_000280; ortho-Benzenediol; Catechol (phenol); ortho-Hydroquinone; ZINC00330145; 16474-90-1; pyrocatechol; benzenediol; Brenzcatechin; 12385-08-9; C01785; EINECS 204-427-5; EU-0100280; nchembio801-comp10; o-Dihydroxybenzene; Durafur Developer CFouramine PCH; o-Hydroxyphenol; Phthalhydroquinone; 16474-89-8; Catechol-pyrocatechol; CCRIS 741; ACM19481108; AI3-03995; Pyrocatechinic acid; CI 76500; Durafur developer C; o-Phenylenediol; 1,2-dihydroxybenzene; ortho-Hydroxyphenol; Oxyphenic acid; BRN 0471401; c0097; pyrocatechol-ul-14C; CAQ; 37349-32-9; ortho-Dihydroxybenzene; AIDS-108194; C3561_SIAL; o-Benzenediol; ortho-Dioxybenzene; Katechol [Czech]; Pelagol Grey C; Pyrokatechol [Czech]; AIDS108194; Pyrocatechinic acidPyrocatechol; WLN: QR BQ; Pyrocatechine; 1,2-benzenediol; o-Hydroquinone; CATECHOL; Benzene, o-dihydroxy-; pyrocatechin; ortho-Phenylenediol; HSDB 1436; C9593_SIGMA; NSC1573; C.I. 76500;pyrocatechol;o-hydroquinone;o-phenylenediol;1,2-benzenediol C6H6O2 110.11 g/mol C1=CC=C(C(=C1)O)O
TCMBANKIN058503 gambiriin a 1 gambiriin A-1 C30H28O12 580.5 g/mol C1C(C(OC2=C1C(=CC(=C2C(C3=CC(=C(C=C3)O)O)C(CC4=C(C=C(C=C4O)O)O)O)O)O)C5=CC(=C(C=C5)O)O)O
TCMBANKIN058521 (-)-epicatechin-3-gallate epicatechin-3-gallate; L-Epicatechin gallate; (-)-epicatechin gallate; (+)- Catechin gallate table; catechin gallate; 7-o-galloyl- (+) -catechin; (-)-epicatechin-3-o-gallate; (?)-epicatechin-3-o-gallate; (-)-Catechin gallate; Epicatechin gallate; (-)-Epicatechin-3-gallate; KBioSS_000794; 1257-08-5; DivK1c_006371; Spectrum2_000165; NSC 636594; KBioGR_001980; Epicatechol, 3-gallate, (-)- (8CI); [(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl] 3,4,5-trihydroxybenzoate; (−)-Epicatechin gallate; SPECTRUM210238; KBio2_003362; [(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychroman-3-yl] 3,4,5-trihydroxybenzoate; MEGxp0_000810; KBio1_001315; (-)-Epicatechin gallate; SpecPlus_000275; BSPBio_001632; KBio2_000794; SPBio_000029; (−)-cis-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate; Spectrum5_000080; SDCCGMLS-0066549.P001; Spectrum3_000246; E3893_SIAL; Spectrum_000314; Epicatechol, gallate (6CI); 3,4,5-trihydroxybenzoic acid [(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl] ester; KBio3_001132; Spectrum4_001540; Benzoic acid, 3,4,5-trihydroxy-, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester, (2R-cis)-; Benzoic acid, 3,4,5-trihydroxy-, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7- dihydroxy-2H-1-benzopyran-3-yl ester, (-)-cis-; AIDS000675; 3,4,5-trihydroxybenzoic acid [(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-chromanyl] ester; KBio2_005930; Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester; (−)-cis-3,3′,4′,5,7-Pentahydroxyflavane 3-gallate; AIDS-000675; catechin gallate ; catechin-3 gallate; CG; 7-o-galloyl-(+)-catechin; (-)-Epicatechin-3-O-gallate,; (-)-Epicatechin-3-gallate,; (-)-epicatechin 3-o-gallate ; SpecPlus_000275; (-)-Epicatechin gallate; KBioSS_000794; [(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychroman-3-yl] 3,4,5-trihydroxybenzoate; Benzoic acid, 3,4,5-trihydroxy-, (2S,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester; LMPK12020090; KBio2_003362; ECG; 92587OVD8Z; 1257-08-5; 3,4,5-Trihydroxybenzoic Acid (2R,3R)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl Ester; AS-15722; Benzoic acid, 3,4,5-trihydroxy-, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester, (2R-cis)-; UNII-92587OVD8Z; KBio3_001132; 3-Galloyl-(2R,3R)-(-)-Epicatechin; SR-05000002675; (-)-cis-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate; CCG-38376; (-) epicatechin gallate; NSC636594; 3,4,5-Trihydroxy-benzoic acid 2-(3,4-dihydroxy-phenyl)-5,7-dihydroxy-chroman-3-yl ester; 3-O-Galloylepicatechin; CHEMBL36327; BDBM50153015; (-)-epicatechingallate; Epicatechin gallate; (-)-cis-3,3',4',5,7-Pentahydroxyflavane 3-gallate; AM84365; Q-200002; Epicatechol, 3-gallate, (-)-; ZINC3978503; SCHEMBL39047; C-22380; KBio1_001315; (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate; epi-Catechin 3-O-gallate; MolPort-001-740-964; (-)-epi-Catechin 3-O-gallate; DivK1c_006371; Epicatechol, gallate (6CI); (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate; C22H18O10; Benzoic acid, 3,4,5-trihydroxy-, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7- dihydroxy-2H-1-benzopyran-3-yl ester, (-)-cis-; BRD-K50660797-001-01-0; NSC 636594; epicatechin-3-O-gallate; Epicatechin 3-gallate; (-)-Epicatechin-3-gallate; (-)-Epicatechin gallate,; (-)epicatechingallate; HY-N0002; epicatechin gallate, (2R-cis)-isomer; L-Epicatechin gallate; NCGC00179135-01; (-)-Epicatechin-3-O-gallate; KBio2_000794; SDCCGMLS-0066549.P001; CTK8E0233; epicatechin monogallate; CS-3761; BSPBio_001632; 3,4,5-Trihydroxy-benzoic acid (2R,3R)-2-(3,4-dihydroxy-phenyl)-5,7-dihydroxy-chroman-3-yl ester; 2.57E+87; AC-6037; AN-48941; Teatannin; Spectrum_000314; Spectrum5_000080; MEGxp0_000810; [(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate; Epicatechin gallate, primary pharmaceutical reference standard; Spectrum2_000165; (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychroman-3-yl 3,4,5-trihydroxybenzoate; Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester; Epicatechol, gallate; NP-002326; AC1L32YN; 3-Galloyl-(-)-epicatechin; (-)-Epicatechin 3-O-gallate; SPECTRUM210238; SPBio_000029; ST24033389; AC1Q5X10; Epicatechol, 3-gallate, (-)- (8CI); KBio2_005930; AJ-47571; MCULE-8110076741; Spectrum4_001540; epicatechin gallate (ECG); E0890; [(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl] 3,4,5-trihydroxybenzoate; (-)-Epicatechin gallate, >=98% (HPLC), from green tea; AKOS015965216; SR-05000002675-1; 3-Gallate(-)-Epicatechol; CHEBI:70255; KB-277863; LS-38401; LSHVYAFMTMFKBA-TZIWHRDSSA-N; (-)-cis-3,3 inverted exclamation marka,4 inverted exclamation marka,5,7-Pentahydroxyflavane 3-gallate; MFCD00075936; AX8001457; AB0017581; KBioGR_001980; Spectrum3_000246; CE0014; Q429; AIDS-231457; [(2R,3S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychroman-3-yl] 3,4,5-trihydroxybenzoate; 3,4,5-trihydroxybenzoic acid [(2R,3S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl] ester; [(2R,3S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl] 3,4,5-trihydroxybenzoate; Benzoic acid, 3,4,5-trihydroxy-, (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester; 3,4,5-trihydroxybenzoic acid [(2R,3S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-chromanyl] ester; AIDS231457; 3,4,5-trihydroxybenzoic acid [(2S,3S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl] ester; (-)-epicatechin gallate; epicatechin-3 gallate; 3,4,5-trihydroxybenzoic acid [(2S,3S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-chromanyl] ester; epicatechin gallate ; [(2S,3S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychroman-3-yl] 3,4,5-trihydroxybenzoate; Epicatechin-3-gallate; [(2S,3S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl] 3,4,5-trihydroxybenzoate; epicatechin gallate; Benzoic acid, 3,4,5-trihydroxy-, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester, cis-; Epicatechin-3-galloyl ester; 863-03-6 C22H18O10 442.4 g/mol C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O
TCMBANKIN058522 procyanidin b5-3'-o-gallate proanthocyanidins; amurensisin; procyanidin; Proantho Cyanidins; procyanidins; FT-0688150; AN-8386; 2-(3,4-DIHYDROXYPHENYL)-2-{[2-(3,4-DIHYDROXYPHENYL)-5,7-DIHYDROXY-3,4-DIHYDRO-2H-1-BENZOPYRAN-3-YL]OXY}-3,4-DIHYDRO-1-BENZOPYRAN-3,4,5,7-TETROL; Y0170; epicatechin-4alpha,8-epicatechin; 2-(3,4-dihydroxyphenyl)-2-[[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl]oxy]-3,4-dihydrochromene-3,4,5,7-tetrol; 2-(3,4-dihydroxyphenyl)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl]oxy-chromane-3,4,5,7-tetrol; 4852-22-6; AC1L32WW; Procyanidin; AKOS025402316; 2-(3,4-dihydroxyphenyl)-2-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2h-chromen-3-yl]oxy}chromane-3,4,5,7-tetrol; Procyanidin B-5 3'-O-gallate; SCHEMBL15091123; LS-39919; MFCD01662851; Procyanidins; C30H26O13; 2-(3,4-Dihydroxyphenyl)-2-((2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl)oxy)-3,4-dihydro-2H-1-benzopyran-3,4,5,7-tetrol; AK321485; 3,3',4,4',5,7-Flavanhexol, 2-((2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-chromanyl)oxy)-; 2-(3,4-Dihydroxyphenyl)-2-((2-(3,4-dihydroxyphenyl)-5,7-dihydroxychroman-3-yl)oxy)chroman-3,4,5,7-tetraol; AC-8032; KS-00000PUZ; MolPort-009-758-937; 2H-1-Benzopyran-3,4,5,7-tetrol, 2-(3,4-dihydroxyphenyl)-2-((2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl)oxy)-3,4-dihydro-; DTXSID90858698; X1211; 20347-71-1; BG01192546; 852P226; BRN 1675863; AC1Q7ACM C30H26O13 594.5 g/mol C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC4(C(C(C5=C(C=C(C=C5O4)O)O)O)O)C6=CC(=C(C=C6)O)O
TCMBANKIN058524 gambiriin B-3 gambiriin b 3 C30H26O11 562.5 g/mol C1C(C(OC2=CC3=C(C(C(O3)CC4=C(C=C(C=C4O)O)O)C5=CC(=C(C=C5)O)O)C(=C21)O)C6=CC(=C(C=C6)O)O)O
TCMBANKIN058561 sanguiinh2 sanguiin h2;sanguiin H-2 C48H32O31 1104.7 g/mol C1C2C(C3C(C(O2)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5C6=C(C(=C(C=C6C(=O)O3)O)O)O)O)O)O)OC(=O)C7=C(C8=C(C(=C(C=C8C(=O)O1)O)O)O)C(=C(C(=C7OC9=CC(=CC(=C9O)O)C(=O)O)O)O)O
TCMBANKIN058564 sanguiinh6 sanguiin h6 C82H54O52 1871.3 g/mol C1C2C(C3C(C(O2)OC(=O)C4=CC(=C(C(=C4)OC5=C(C(=C(C6=C5C(=O)OC7C(COC(=O)C8=CC(=C(C(=C86)O)O)O)OC(C9C7OC(=O)C2=CC(=C(C(=C2C2=C(C(=C(C=C2C(=O)O9)O)O)O)O)O)O)OC(=O)C2=CC(=C(C(=C2)O)O)O)O)O)O)O)O)OC(=O)C2=CC(=C(C(=C2C2=C(C(=C(C=C2C(=O)O3)O)O)O)O)O)O)OC(=O)C2=CC(=C(C(=C2C2=C(C(=C(C=C2C(=O)O1)O)O)O)O)O)O
TCMBANKIN059200 ponalactone a 33722-77-9; AC1L9C7T; C09174; DTXSID90331734; Ponalactone A; CHEBI:8330;inumakilactone d;9, 12, 15-- octadecadienoic acid;10,13-Methyl octadecadienoate;(Cis, cis, cis)-9,12,15- octadecadienoic acid C19H22O6 346.4 g/mol CC(C)C1C2=CC3C4C(C(C5C(C4(C2=CC(=O)O1)C)O5)O)(C(=O)O3)C
TCMBANKIN059632 HN saponin F C41H66O13 767 g/mol CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)CO)OC6C(C(C(CO6)O)O)O)C)C)C2C1)C)C(=O)OC7C(C(C(C(O7)CO)O)O)O)C
TCMBANKIN059750 sanguisorbigenin C30H46O3 454.68 CC1=C(C2C3=CCC4C5(CCC(C(C5CCC4(C3(CCC2(CC1)C(=O)O)C)C)(C)C)O)C)C
TCMBANKIN060043 3-methyl-6,7,8-trihydropyrrolo[1,2-a]pyrimidin-2-one C8H10N2O 150.18 g/mol CC1=CN2CCCC2=NC1=O
TCMBANKIN060222 28-o-beta-d-glucopyrnosyl-(1-6)-beta-d-glucopyranosyl ester of 3-o-[beta-d-glucopyranosyl-(1-4)][alpha-l-rhamno-pyranosyl-(1-3)]-beta-d-gluco-pyrano-syl-(1-3)-alpha-l-rhamno-pyranosyl-(1-2)-alpha-arabi-nopyranosyl-hederagenin C71H116O36 CC1C(C(C(C(O1)OC2C(C(OC(C2OC3C(C(C(C(O3)CO)O)O)O)CO)OC4C(C(OC(C4O)OC5C(C(COC5OC6CCC7(C(C6(C)CO)CCC8(C7CC=C9C8(CCC1(C9CC(CC1)(C)C)C(=O)OC1C(C(C(C(O1)COC1C(C(C(C(O1)CO)O)O)O)O)O)O)C)C)C)O)O)C)O)O)O)O)O
TCMBANKIN060410 13-oxyingenol C20H28O6 364.4 g/mol CC1CC2(C(C2(C)C)C3C=C(C(C4(C1(C3=O)C=C(C4O)C)O)O)CO)O
TCMBANKIN060529 Tormentic acid C30H48O5 488.7 g/mol CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1(C)O)C)C(=O)O
TCMBANKIN060536 asiatic acid C30H48O5 488.7 CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1C)C)C(=O)O
TCMBANKIN060538 3-oxo-19α-hydroxyurs-12-en-28-oic acid C30H46O4 634.54 CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(=O)C5(C)C)C)C)C2C1(C)O)C)C(=O)O
TCMBANKIN060553 Ziyuglycoside I C41H66O13 767 g/mol CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(CO6)O)O)O)C)C)C2C1(C)O)C)C(=O)OC7C(C(C(C(O7)CO)O)O)O
TCMBANKIN060554 sanguisorbin b C35H56O7 588.8 g/mol CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(CO6)O)O)O)C)C)C2C1C)C)C(=O)O
TCMBANKIN060693 Sitogluside C35H60O6 576.85g/mol CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C
TCMBANKIN061393 dehydrochebulic acid trimethyl ester trimethyl ester dehydrochebulic acid C17H16O11 396.3 g/mol COC(=O)C=C(C1C(OC(=O)C2=CC(=C(C(=C12)O)O)O)C(=O)OC)C(=O)OC
TCMBANKIN061823 3,5,6-trihydroxy-7,4'-dimethoxyflavone 3,5,6-Thdmof; DTXSID80244086; 3,5,6-Trihydroxy-7,4'-dimethoxyflavone; AC1NT15C; LMPK12112872; 4H-1-Benzopyran-4-one, 3,5,6-trihydroxy-2-(4-methoxyphenyl)-; 3,5,6-trihydroxy-7-methoxy-2-(4-methoxyphenyl)chromen-4-one; 3,5,6-Trihydroxy-4',7'-dimethoxyflavone; 99499-82-8; 3,5,6-trihydroxy-4',7-dimethoxyflavone C17H14O7 330.29 g/mol COC1=CC=C(C=C1)C2=C(C(=O)C3=C(C(=C(C=C3O2)OC)O)O)O
TCMBANKIN061892 limettin HMS501D13; MolPort-003-665-736; AC1L1EFT; 5-18-03-00199 (Beilstein Handbook Reference); ACMC-1AM7E; C-10266; A827593; BSPBio_003016; CTK4J0961; NCGC00254844-01; HMS1921E18; Coumarin derivative, 2a; KBio2_003291; AI3-36094; LS-55181; CC-20975; 5,7-Dimethoxy-2H-1-benzo-pyran-2-one; Citropten, analytical standard; AK167951; 5,7-Dimethoxy-2-benzopyrone; DB-051575; DivK1c_000391; CAS-487-06-9; NSC217987; FT-0619848; SR-05000002446-1; NINDS_000391; ST50319835; Spectrum_000243; Tox21_300942; InChI=1/C11H10O4/c1-13-7-5-9(14-2)8-3-4-11(12)15-10(8)6-7/h3-6H,1-2H3; DTXSID1041421; Limettin; NCGC00094841-02; MCULE-8767481325; TC-168439; AQ-358/43417403; NCGC00178344-01; SMR000112321; OR345352; MLS002703744; SDCCGMLS-0066597.P001; KB-73158; IDI1_000391; 5,7-dimethoxy-coumarin; NSC102793; 2H-1-Benzopyran-2-one, 5,7-dimethoxy-; 9155AF; CHEMBL481049; 5,7-Dimethoxy-2H-1-benzopyran-2-one; Spectrum5_001348; SCHEMBL516577; DSSTox_CID_21421; 5,7-Dimethoxy-2H-chromen-2-one; citropten; EINECS 207-646-4; I14-52904; MLS002472928; DSSTox_GSID_41421; CCG-40277; HMS2268I06; NXJCRELRQHZBQA-UHFFFAOYSA-; NSC 102793; KBioGR_001222; AKOS015915990; KBio2_000723; 487D069; KBio2_005859; Spectrum3_001398; CHEBI:113528; BRD-K78612426-001-02-6; COUMARIN, 5,7-DIMETHOXY-; AN-45243; Citraptene; NCGC00094841-03; Spectrum2_000814; 5, 7-Dimethoxycoumarin; NCGC00094841-01; 5,7-dimethoxychromen-2-one; Spectrum4_000781; BDBM93217; KBio3_002236; NSC-102793; JWE1QQ247N; Limetin; 5,7-Dimethyloxy-2H-1-benzopyran-2-one; CCRIS 3595; NSC-217987; DSSTox_RID_79725; 487-06-9; SPECTRUM1500707; NXJCRELRQHZBQA-UHFFFAOYSA-N; SR-05000002446; Citroptene; 2H-1-Benzopyran-2-one,5,7-dimethoxy-; SPBio_000707; 5,7-dimethoxy-1-benzopyran-2-one; 5,7-Dimethoxycoumarin, 98%; UNII-JWE1QQ247N; KBio1_000391; ZINC57754; AC-20780; 5,7-Dimethoxy-chromen-2-one; NCGC00094841-04; 5,7-Dimethoxycoumarin; 2H-1-Benzopyran-2-one,7-dimethoxy-; MLS002207304; KBioSS_000723; MFCD00006870; BRN 0187066; ZB002255; Coumarin,7-dimethoxy-; citropten; Limetin; 5, 7- dimethoxy coumarin; HMS501D13; MolPort-003-665-736; AC1L1EFT; 5-18-03-00199 (Beilstein Handbook Reference); ACMC-1AM7E; C-10266; A827593; BSPBio_003016; CTK4J0961; NCGC00254844-01; HMS1921E18; Coumarin derivative, 2a; KBio2_003291; AI3-36094; LS-55181; CC-20975; 5,7-Dimethoxy-2H-1-benzo-pyran-2-one; Citropten, analytical standard; AK167951; 5,7-Dimethoxy-2-benzopyrone; DB-051575; DivK1c_000391; CAS-487-06-9; NSC217987; FT-0619848; SR-05000002446-1; NINDS_000391; ST50319835; Spectrum_000243; Tox21_300942; InChI=1/C11H10O4/c1-13-7-5-9(14-2)8-3-4-11(12)15-10(8)6-7/h3-6H,1-2H3; DTXSID1041421; Limettin; NCGC00094841-02; MCULE-8767481325; TC-168439; AQ-358/43417403; NCGC00178344-01; SMR000112321; OR345352; MLS002703744; SDCCGMLS-0066597.P001; KB-73158; IDI1_000391; 5,7-dimethoxy-coumarin; NSC102793; 2H-1-Benzopyran-2-one, 5,7-dimethoxy-; 9155AF; CHEMBL481049; 5,7-Dimethoxy-2H-1-benzopyran-2-one; Spectrum5_001348; SCHEMBL516577; DSSTox_CID_21421; 5,7-Dimethoxy-2H-chromen-2-one; EINECS 207-646-4; I14-52904; MLS002472928; DSSTox_GSID_41421; CCG-40277; HMS2268I06; NXJCRELRQHZBQA-UHFFFAOYSA-; NSC 102793; KBioGR_001222; AKOS015915990; KBio2_000723; 487D069; KBio2_005859; Spectrum3_001398; CHEBI:113528; BRD-K78612426-001-02-6; COUMARIN, 5,7-DIMETHOXY-; AN-45243; Citraptene; NCGC00094841-03; Spectrum2_000814; 5, 7-Dimethoxycoumarin; NCGC00094841-01; 5,7-dimethoxychromen-2-one; Spectrum4_000781; BDBM93217; KBio3_002236; NSC-102793; JWE1QQ247N; Limetin; 5,7-Dimethyloxy-2H-1-benzopyran-2-one; CCRIS 3595; NSC-217987; DSSTox_RID_79725; 487-06-9; SPECTRUM1500707; NXJCRELRQHZBQA-UHFFFAOYSA-N; SR-05000002446; Citroptene; 2H-1-Benzopyran-2-one,5,7-dimethoxy-; SPBio_000707; 5,7-dimethoxy-1-benzopyran-2-one; 5,7-Dimethoxycoumarin, 98%; UNII-JWE1QQ247N; KBio1_000391; ZINC57754; AC-20780; 5,7-Dimethoxy-chromen-2-one; NCGC00094841-04; 5,7-Dimethoxycoumarin; 2H-1-Benzopyran-2-one,7-dimethoxy-; MLS002207304; KBioSS_000723; MFCD00006870; BRN 0187066; ZB002255; Coumarin,7-dimethoxy-; Spectrum5_001348; AIDS026325; 5,7-Dimethoxy-2-benzopyrone; ZINC00057754; EINECS 207-646-4; CCRIS 3595; DivK1c_000391; NSC217987; NINDS_000391; 487-06-9; SPECTRUM1500707; Spectrum_000243; ST5319835; Citroptene; Limettin; SPBio_000707; CITROPTEN; NCGC00094841-02; 5-18-03-00199 (Beilstein Handbook Reference); NSC 102793; KBio1_000391; KBioGR_001222; 116238_ALDRICH; BSPBio_003016; KBio2_000723; KBio2_005859; Spectrum3_001398; 5,7-Dimethoxycoumarin; AIDS-026325; AI3-36094; KBio2_003291; SDCCGMLS-0066597.P001; IDI1_000391; Citraptene; 5,7-dimethoxy-2-chromenone; KBioSS_000723; Spectrum2_000814; 5,7-dimethoxy-coumarin; BRN 0187066; NSC102793; 2H-1-Benzopyran-2-one, 5,7-dimethoxy-; 5,7-dimethoxychromen-2-one; Coumarin, 5,7-dimethoxy-; Spectrum4_000781; NCGC00094841-01; KBio3_002236 C11H10O4 206.19 g/mol COC1=CC2=C(C=CC(=O)O2)C(=C1)OC
TCMBANKIN061904 methyl 6-o-galloy-beta-d-glucopyranoside methyl-6-O-galloyl-β-D-glucopyranoside;methyl-6-o-galloyl-β-d-glucopyranoside C14H18O10 346.32 COC1C(C(C(C(O1)COC(=O)C2=CC(=C(C(=C2)O)O)O)O)O)O
TCMBANKIN061905 methyl 6-o-digalloyl-β-d-glucopyranoside i [2,3-dihydroxy-5-[[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-methoxyoxan-2-yl]methoxycarbonyl]phenyl] 3,4,5-trihydroxybenzoate; AC1NSYBB; methyl 6-o-digalloyl-beta-d-glucopyranoside(ii) COC1C(C(C(C(O1)COC(=O)C2=CC(=C(C(=C2)OC(=O)C3=CC(=C(C(=C3)O)O)O)O)O)O)O)O
   植物对应的疾病
疾病ID 病名 疾病类型 MeSH 参考文献
   植物对应的靶点
靶点ID 基因名 基因别名 描述 染色体位置 Map_Location 基因类型

Home | Browse | Search | Predict | Data | Contact | Help

Copyright © KUST | 滇ICP备16009434号-1 | Dai SX Lab